Growth hormone secretagogues reduce transient outward K+ current via phospholipase C/protein kinase C signaling pathway in rat ventricular myocytes

Endocrinology

Volumn 151, Issue 3, 2010, Pages 1228-1235

  Sun, Qiang ^a,b,c   Zang, Wei Jin ^a   Chen, Chen ^b,c  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 5 METHOXY 1H INDOL 3 YL] 3 (1H INDOL 3 YL)MALEIMIDE; BIM 28163; CALPHOSTIN C; GHRELIN; HEXARELIN; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NYSTATIN; PHOSPHOLIPASE C; PROTEIN INHIBITOR; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ANIMAL CELL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DRUG MECHANISM; HEART MUSCLE CELL; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT;

ACTION POTENTIALS; ANIMALS; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GHRELIN; MALE; MYOCYTES, CARDIAC; OLIGOPEPTIDES; PHOSPHOLIPASE C BETA; POTASSIUM; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GHRELIN; SIGNAL TRANSDUCTION;

EID: 77149172852     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0877     Document Type: Article

References (34)

1. Nagaya N, Uematsu M, Kojima M, Ikeda Y, Yoshihara F, Shimizu W, Hosoda H, Hirota Y, Ishida H, Mori H, Kangawa K 2001 Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 104:1430-1435
2. Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni S, Fubini A, Malan D, Baj G, Granata R, Broglio F, Papotti M, Surico N, Bussolino F, Isgaard J, Deghenghi R, Sinigaglia F, Prat M, Muccioli G, Ghigo E, Graziani A 2002 Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 159:1029-1037
3. Benso A, Broglio F, Marafetti L, Lucatello B, Seardo MA, Granata R, Martina V, Papotti M, Muccioli G, Ghigo E 2004 Ghrelin and synthetic growth hormone secretagogues are cardioactive molecules with identities and differences. Semin Vasc Med 4:107-114
4. Cao JM, Ong H, Chen C 2006 Effects of ghrelin and synthetic GH secretagogues on the cardiovascular system. Trends Endocrinol Metab 17:13-18
5. Xu XB, Pang JJ, Cao JM, Ni C, Xu RK, Peng XZ, Yu XX, Guo S, Chen MC, Chen C 2005 GH-releasing peptides improve cardiac dysfunction and cachexia and suppress stress-related hormones and cardiomyocyte apoptosis in rats with heart failure. Am J Physiol Heart Circ Physiol 289:H1643-H1651
6. Pang JJ, Xu RK, Xu XB, Cao JM, Ni C, Zhu WL, Asotra K, Chen MC, Chen C 2004 Hexarelin protects rat cardiomyocytes from angiotensin II-induced apoptosis in vitro. Am J Physiol Heart Circ Physiol 286:H1063-H1069
7. Frascarelli S, Ghelardoni S, Ronca-Testoni S, Zucchi R 2003 Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart. Basic Res Cardiol 98:401-405
8. Iwase M, Kanazawa H, Kato Y, Nishizawa T, Somura F, Ishiki R, Nagata K, Hashimoto K, Takagi K, Izawa H, Yokota M 2004 Growth hormone-releasing peptide can improve left ventricular dysfunction and attenuate dilation in dilated cardiomyopathic hamsters. Cardiovasc Res 61:30-38
9. Iglesias MJ, Piñeiro R, Blanco M, Gallego R, Diéguez C, Gualillo O, González-Juanatey JR, Lago F 2004 Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes. Cardiovasc Res 62:481-488
10. Soares JB, Rocha-Sousa A, Castro-Chaves P, Henriques-Coelho T, Lourenco AP, Roncon-Albuquerque Jr R, Leite-Moreira AF 2005 Contractile effects of ghrelin and expression of its receptor GHSR1a in normal and hypertrophic myocardium. Rev Port Cardiol 24:1235-1242
11. + current densities in rat ventricle. Life Sci 63:391-400
12. Greenstein JL, Wu R, Po S, Tomaselli GF, Winslow RL 2000 Role of the calcium-independent transient outward current I(to1) in shaping action potential morphology and duration. Circ Res 87:1026-1033
13. Xu XB, Cao JM, Pang JJ, Xu RK, Ni C, Zhu WL, Asotra K, Chen MC, Chen C 2003 The positive inotropic and calcium-mobilizing effects of growth hormone-releasing peptides on rat heart. Endocrinology 144:5050-5057
14. Zang WJ, Yu XJ, Honjo H, Kirby MS, Boyett MR 1993 On the role of G protein activation and phosphorylation in desensitization to acetylcholine in guinea-pig atrial cells. J Physiol 464:649-679
15. Fernández-Velasco M, Ruiz-Hurtado G, Hurtado O, Moro MA, Delgado C 2007 TNF-α downregulates transient outward potassium current in rat ventricular myocytes through iNOS overexpression and oxidant species generation. AmJ Physiol Heart Circ Physiol 293:H238-H245
16. Halem HA, Taylor JE, Dong JZ, Shen Y, Datta R, Abizaid A, Diano S, Horvath T, Zizzari P, Bluet-Pajot MT, Epelbaum J, Culler MD 2004 Novel analogs of ghrelin: physiological and clinical implications. Eur J Endocrinol 151(Suppl 1):S71-S75
17. Halem HA, Taylor JE, Dong JZ, Shen Y, Datta R, Abizaid A, Diano S, Horvath TL, Culler MD 2005 A novel growth hormone secretagogue-1a receptor antagonist that blocks ghrelin-induced growth hormone secretion but induces increased body weight gain. Neuroendocrinology 81:339-349
18. Zheng L, PaikWY,Cesnjaj M, Balla T, Tomiæ M, Catt KJ, Stojilkovic SS 1995 Effects of the phospholipase-C inhibitor, U73122, on signaling and secretion in pituitary gonadotrophs. Endocrinology 136:1079-1088
19. Kojima M, Kangawa K 2005 Ghrelin: structure and function. Physiol Rev 85:495-522
20. Nagaya N, Kojima M, Uematsu M, Yamagishi M, Hosoda H, Oya H, Hayashi Y, Kangawa K 2001 Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol 280:R1483-R1487
21. Bodosi B, Gardi J, Hajdu I, Szentirmai E, Obal Jr F, Krueger JM 2004 Rhythms of ghrelin, leptin, and sleep in rats: effects of the normal diurnal cycle, restricted feeding, and sleep deprivation.AmJ Physiol Regul Integr Comp Physiol 287:R1071-R1079
22. Davenport AP, Bonner TI, Foord SM, Harmar AJ, Neubig RR, Pin JP, Spedding M, Kojima M, Kangawa K 2005 International Union of Pharmacology. LVI. Ghrelin receptor nomenclature, distribution, and function. Pharmacol Rev 57:541-546
23. Chen C, Wu D, Clarke IJ 1996 Signal transduction systems employed by synthetic GH-releasing peptides in somatotrophs. J Endocrinol 148:381-386
24. Wu D, Clarke IJ, Chen C 1997 The role of protein kinase C in GH secretion induced by GH-releasing factor and GH-releasing peptides in cultured ovine somatotrophs. J Endocrinol 154:219-230
25. Bogoyevitch MA, Parker PJ, Sugden PH 1993 Characterization of protein kinase C isotype expression in adult rat heart. Protein kinase C-ε is a major isotype present, and it is activated by phorbol esters, epinephrine, and endothelin. Circ Res 72:757-767
26. + currents in rat ventricular myocytes and its modification by hormonal status. J Physiol 520(Pt 2):439-449
27. + current via a cAMP/PKA-mediated pathway in the rat heart. Am J Physiol Cell Physiol 288:C577-C585
28. + current in rat ventricle. Am J Physiol 276:H1599-H1607
29. 2+ homeostasis in the heart: beyond the action potential. Braz J Med Biol Res 39:393-403
30. + current, by PKC. Am J Physiol 273:H1775-H1786
31. Schrader LA, Ren Y, Cheng F, Bui D, Sweatt JD, Anderson AE 2009 Kv4.2 is a locus for PKC and ERK/MAPK cross-talk. Biochem J 417:705-715
32. Jia Y, Takimoto K 2006 Mitogen-activated protein kinases control cardiac KChIP2 gene expression. Circ Res 98:386-393
33. + currents by angiotensin and endothelin. Am J Physiol Heart Circ Physiol 284:H1168-H1181
34. van der Heyden MA, Wijnhoven TJ, Opthof T 2006 Molecular aspects of adrenergic modulation of the transient outward current. Cardiovasc Res 71:430-442